Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
Marlies J. W. Peeters, Anne Rahbech, Per thor Straten
Cancer Immunology Immunotherapy (2019) Vol. 69, Iss. 2, pp. 237-244
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
Nabil F. Saba, Conor Steuer, Asari Ekpenyong, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 880-887
Open Access | Times Cited: 46
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects
Solange Peters, Luis Paz‐Ares, Roy S. Herbst, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004863-e004863
Open Access | Times Cited: 43
TAM Receptor Inhibition–Implications for Cancer and the Immune System
Pia Aehnlich, Richard Powell, Marlies J. W. Peeters, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1195-1195
Open Access | Times Cited: 55
Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy
Zan Dai, Qiaoyun Wang, Jie Tang, et al.
Biomaterials (2021) Vol. 280, pp. 121261-121261
Closed Access | Times Cited: 46
MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells
Marlies J. W. Peeters, Donata Dulkeviciute, Arianna Draghi, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 9, pp. 1472-1484
Open Access | Times Cited: 47
Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis
Anna Tutusaus, Montserrat Marı́, Jose T. Ortiz‐Pérez, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2186-2186
Open Access | Times Cited: 45
The complex roles of efferocytosis in cancer development, metastasis, and treatment
Amir Tajbakhsh, Seyed Mohammad Gheibi Hayat, Ahmad Movahedpour, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111776-111776
Open Access | Times Cited: 39
Targeting nanoparticles to malignant tumors
Nikita Sharma, Kais Bietar, Ursula Stochaj
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188703-188703
Closed Access | Times Cited: 25
Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis
Qing Niu, Jinfang Gao, Lei Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
CD14+CD16− monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK
Jimeng Xue, Liling Xu, Huaqun Zhu, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 35
New approaches to first-line treatment of advanced renal cell carcinoma
Daniel J. George, Chung‐Han Lee, Daniel Y.C. Heng
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 31
Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies
Jinghang Xie, Fadi El Rami, Kaixiang Zhou, et al.
ACS Central Science (2022) Vol. 8, Iss. 5, pp. 590-602
Open Access | Times Cited: 21
Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo Efficacy
William McCoull, Scott Boyd, Martin R. Brown, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13524-13539
Closed Access | Times Cited: 23
LncRNA LOC100129620 promotes osteosarcoma progression through regulating CDK6 expression, tumor angiogenesis, and macrophage polarization
Yong Chen, Guoqing Tang, Hongbin Qian, et al.
Aging (2021) Vol. 13, Iss. 10, pp. 14258-14276
Open Access | Times Cited: 21
Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
Jeff Hsu, Colin Chong, Jeffrey D. Serrill, et al.
Molecular Cancer Therapeutics (2022) Vol. 22, Iss. 2, pp. 179-191
Open Access | Times Cited: 12
GAS6/TAM Axis as Therapeutic Target in Liver Diseases
Anna Tutusaus, Albert Morales, Pablo Garcı́a de Frutos, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 01, pp. 099-114
Open Access | Times Cited: 2
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
Yi‐Yun Yu, Miyeon Jang, Julie M. Miyashiro, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17000-17032
Closed Access | Times Cited: 2
Immunological role of TAM receptors in the cancer microenvironment
Varsha Gadiyar, Gopi Patel, Viralkumar Davra
International review of cell and molecular biology (2020), pp. 57-79
Closed Access | Times Cited: 18
Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment
Grégory Hamm, Gareth Maglennon, Beth Williamson, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 2, pp. 613-624
Open Access | Times Cited: 11
Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
Yunxiang Zhou, Yali Wang, Hailong Chen, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 14
Decoding cancer’s camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade
Maria L. Lotsberg, Austin Rayford, Jean Paul Thiery, et al.
Cancer Drug Resistance (2020)
Open Access | Times Cited: 13
Aberrant expressions of TAM receptors are associated with postoperative recurrence in chronic rhinosinusitis with nasal polyps
Yandan Zhou, Zhili Feng, Wen Jie, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 6, pp. 3005-3015
Closed Access | Times Cited: 1
Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?
Daria Apostolo, Davide D’Onghia, Alessandra Nerviani, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 7486-7504
Open Access | Times Cited: 1
Functions of TAM Receptors and Ligands Protein S and Gas6 in Atherosclerosis and Cardiovascular Disease
Teagan Prouse, Samarpan Majumder, Rinku Majumder
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12736-12736
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top